[INTERVIEW] Recce gearing up for Indonesian trials, page-15

Great interview, thanks Bpharma. After all this time with all the associated hiccups and hold ups I must admit I am still holding on and still believe this company has a massive future.

Hoping for the day when they can actually sell a therapy commercially but more significantly sell a therapy that answers a huge unmet need.

Just the simple idea that an infection caused by many possible different bacteria might be treated with this single compound rather than having to cross match for a specific anti biotic seems life saving.
Good luck to all holders, hopefully current deals can get this over the line.